NeurOp, Inc. is a biotechnology company developing new medicines for central nervous system disorders including depression, neuropathic pain, ischemia (stroke), schizophrenia, and Alzheimer’s and Parkinson’s diseases.
Our Science
Our compounds are designed to target various subunits of N-methyl-D-aspartate (NMDA) receptors.
About Us
Our expertise in a critical signaling pathway in the central nervous system is leading to promising drug compounds.